← Back to catalogue

Lipase Color Liquid

FDA UDI

Class I (US FDA UDI)

by Sentinel Ch. Srl

Identity

Trade Name
Lipase Color Liquid FDA UDI
Generic Name
Lipase IVD, kit, spectrophotometry FDA UDI
Device Name
The Lipase Color Liquid is an In Vitro Diagnostic test used for the determination of the lipase activity in serum and plasma by kinetic colorimetric method. The assay is intended for professional use only. FDA UDI
Model / Reference
17401B FDA UDI
Description
The Lipase Color Liquid is an In Vitro Diagnostic test used for the determination of the lipase activity in serum and plasma by kinetic colorimetric method. The assay is intended for professional use only. FDA UDI

Identifiers

Catalog Number
17401B FDA UDI
Primary DI / UDI-DI
08058056680617 FDA UDI
510(k) Number
K961179 FDA UDI
FDA Product Code
CHI FDA UDI
GMDN Term
Lipase IVD, kit, spectrophotometry FDA UDI

Classification

Device Class
Class I FDA UDI
Regulation Number
862.1465 FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

No

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

Yes

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

Yes

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

No

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

Yes

FDA UDI

Manufacturing Date

No

FDA UDI

Dimensions & Sizes

Size
Total Volume — 49 Milliliter FDA UDI

Category: Lipase IVD, kit, spectrophotometry

Lipase Color Liquid by Sentinel Ch. Srl — Class I — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Similar devices

Also classified as Lipase IVD, kit, spectrophotometry.

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Manufacturer
Sentinel Ch. Srl

Sources (1)

  • FDA UDI e952378d-9a0d-4725-8813-bb4bb4350579 38 fields · synced May 30, 2026